This amendment provides $50,000 each year from the general fund for the Rx Partnership program. The Rx Partnership works through a network of clinic partners to provide brand and generic medications to low-income, uninsured Virginians. The funding will support existing programs to expand utilization by 20 percent during the biennium based upon the growth and success of the existing programs, the significant additional patients due to COVID-19, the loss of access to key brand medications, and the increasing cost of generic medications.